Page last updated: 2024-08-26

peptide elongation factor 2 and resveratrol

peptide elongation factor 2 has been researched along with resveratrol in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baksh, S; Chan, AY; Dolinsky, VW; Dyck, JR; Light, PE; Soltys, CL; Viollet, B1

Other Studies

1 other study(ies) available for peptide elongation factor 2 and resveratrol

ArticleYear
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.
    The Journal of biological chemistry, 2008, Aug-29, Volume: 283, Issue:35

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Mice; Multienzyme Complexes; Myocytes, Cardiac; Peptide Elongation Factor 2; Phenylephrine; Protein Biosynthesis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Stilbenes; Transcription, Genetic

2008